Clinical experience with PSMA-Actinium-225 radioligand therapy in end-stage metastatic castration-resistant prostate cancer patients
Van Der Doelen, M., Mehra, N., Van Oort, I., Janssen, M., Haberkorn, U., Kratochwil, C., Gerritsen, W.Volume:
17
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)31443-X
Date:
March, 2018
File:
PDF, 152 KB
english, 2018